Novartis AG (MEX:NVSN) E10: MXN114.31 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:NVSN Novartis AG MEX:NVSN
70 GF Score
Price MXN2,677.00
GF Value MXN2,262.21
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Novartis AG E10?

Novartis AG MEX:NVSN -1.22% 70 E10 is MXN114.31 as of Jun. 2026. GuruFocus rates MEX:NVSN with a GF Score™ of 70/100 and a GF Value™ of MXN2,262.21 (Modestly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novartis AG's adjusted earnings per share data for the three months ended in Jun. 2026 was MXN29.838. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN114.31 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Novartis AG's average E10 Growth Rate was 5.10% per year. During the past 3 years, the average E10 Growth Rate was 2.20% per year. During the past 5 years, the average E10 Growth Rate was 4.70% per year. During the past 10 years, the average E10 Growth Rate was 2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Novartis AG was 8.70% per year. The lowest was -3.40% per year. And the median was 2.10% per year.

As of today (2026-08-09), Novartis AG's current stock price is MXN2677.00. Novartis AG's E10 for the quarter that ended in Jun. 2026 was MXN114.31. Novartis AG's Shiller PE Ratio of today is 23.42.

During the past 13 years, the highest Shiller PE Ratio of Novartis AG was 25.39. The lowest was 12.94. And the median was 17.75.


Novartis AG  (MEX:NVSN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Novartis AG's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=2677.00/114.31
=23.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Novartis AG was 25.39. The lowest was 12.94. And the median was 17.75.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Novartis AG E10 Related Terms


Novartis AG E10 Historical Data

* Premium members only.

The historical data trend for Novartis AG's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG E10 Chart

Novartis AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 104.77 102.48 106.88 117.33 117.24

Novartis AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 109.86 115.31 117.24 123.03 114.31

MEX:NVSN vs LLY, JNJ, ABBV: E10 Comparison

For the Drug Manufacturers - General subindustry, Novartis AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis AG Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novartis AG's Shiller PE Ratio falls into.


MEX:NVSN
70GF Score
Novartis AG MEX:NVSN
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novartis AG E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novartis AG's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=29.838/108.5600*108.5600
=29.838

Current CPI (Jun. 2026) = 108.5600.

Novartis AG Quarterly Data

per share eps CPI Adj_EPS
201609 15.662 99.604 17.070
201612 8.247 99.380 9.009
201703 13.180 100.040 14.303
201706 15.003 100.285 16.241
201709 15.970 100.254 17.293
201712 16.497 100.213 17.871
201803 15.624 100.836 16.821
201806 65.040 101.435 69.608
201809 12.906 101.246 13.838
201812 10.014 100.906 10.774
201903 14.742 101.571 15.756
201906 55.898 102.044 59.467
201909 17.570 101.396 18.811
201912 9.241 101.063 9.926
202003 22.276 101.048 23.932
202006 18.697 100.743 20.148
202009 18.556 100.585 20.027
202012 18.301 100.241 19.820
202103 18.601 100.800 20.033
202106 25.480 101.352 27.292
202109 25.086 101.533 26.822
202112 148.521 101.776 158.422
202203 19.712 103.205 20.735
202206 15.491 104.783 16.049
202209 14.483 104.835 14.998
202212 13.257 104.666 13.750
202303 19.467 106.245 19.891
202306 19.030 106.576 19.384
202309 14.806 106.570 15.083
202312 68.915 106.461 70.274
202403 21.741 107.355 21.985
202406 29.129 107.991 29.283
202409 30.914 107.468 31.228
202412 29.407 107.128 29.800
202503 37.234 107.722 37.524
202506 38.788 108.075 38.962
202509 37.055 107.710 37.347
202512 22.507 107.200 22.793
202603 29.754 108.060 29.892
202606 29.838 108.560 29.838

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of MXN114.31 mean?
Novartis AG (MEX:NVSN) has a E10 of MXN114.31 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Novartis AG and its competitors.
Is Novartis AG's E10 too high?
Novartis AG's current E10 is MXN114.31. Overall, Novartis AG has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Novartis AG's E10 compare to LLY and JNJ?
Novartis AG's E10 of MXN114.31 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Novartis AG and its competitors. Novartis AG's current E10 is MXN114.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novartis AG stock overvalued right now?
Based on GuruFocus' analysis, Novartis AG (MEX:NVSN) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN2,262.21, compared to a current price of MXN2,677.00 — trading 18.3% above its estimated fair value. The current E10 is MXN114.31. Novartis AG's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Novartis AG (MEX:NVSN), the current E10 is MXN114.31 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novartis AG (MEX:NVSN) Overvalued in 2026?

Based on GuruFocus' analysis, Novartis AG stock appears to be overvalued. The current stock price of MXN2,677.00 is trading 18.3% above its estimated GF Value™ of MXN2,262.21. GuruFocus considers Novartis AG to be Modestly Overvalued.

Key valuation signals for MEX:NVSN:

  • E10: MXN114.31
  • GF Value™: MXN2,262.21 vs. price of MXN2,677.00 (18.3% above fair value)
  • GF Score™: 70/100 with 7 warning signs

No single metric tells the full story. See the MEX:NVSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novartis AG Business Description

Address Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
70GF Score

Get the complete analysis for MEX:NVSN

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,677.00
Price
MXN2,262.21
GF Value